Amid the rapid development of the Guangdong-Hong Kong-Macao Greater Bay Area into a world-class health hub, Guangzhou Royal Lee Cancer Hospital takes “Standing Firm in the Bay Area, Linking to the World” as its strategic pillar. Rooted in the innovative landscape of the Sino-Singapore Guangzhou Knowledge City, it has emerged as a modern oncology platform centered on precision diagnosis and treatment, supported by global resources, and guided by human-centered wellness.

Recently, the hospital was awarded the title of Sino-Singapore Guangzhou Knowledge City International Medical & Wellness Base in recognition of its outstanding strengths in advanced technology, access to international pharmaceuticals, and seamless cross-border services, establishing itself as a new hub for international medical care in the region.

01 Precision Technology Matrix:

Core Strength from Access to Leadership

If internationalization is the direction, cutting-edge technology is the foundation for Royal Lee’s long-term development. The hospital has built a comprehensive technology system covering precision diagnosis, minimally invasive treatment, and state-of-the-art radiotherapy.

In interventional and precision therapy, the hospital’s Minimally Invasive Intervention Center performs a full range of ablation procedures, offering patients minimally invasive, fast-recovery treatment options. Particularly in Yttrium-90 resin microsphere selective internal radiation therapy, Guangzhou Royal Lee Cancer Hospital has become one of the few institutions in South China with mature clinical capabilities, opening new treatment options for many inoperable liver cancer patients.

In advanced radiotherapy, the hospital operates the Royal Lee & Taihe United Proton Center, equipped with internationally advanced proton therapy systems. Known as a “gold-standard tool in cancer radiotherapy,” this technology delivers high-dose radiation precisely to tumors while maximally protecting surrounding healthy organs, providing truly internationally aligned treatment for complex and refractory cancers.

In research translation and multidisciplinary care, as a nationally accredited clinical trial institution, the hospital deeply participates in domestic and international clinical trials of new anti-cancer drugs. Through a standardized multidisciplinary team (MDT) model, every treatment plan is developed and verified in accordance with international standards.

02 Pharmaceutical Expressway:

Royal Lee’s Solution to Improving Drug Access

Access to international anti-cancer drugs is a core competitive advantage of Royal Lee. Supported by an efficient global and domestic direct procurement network, the hospital stocks more than 100 imported and specialty drugs covering oncology, cardiovascular diseases, rare diseases, and other fields, enabling rapid response to urgent clinical needs.

Through its unique 48-Hour Smooth Admission Green Channel and compliant temporary procurement processes, the hospital breaks through traditional drug access barriers, ensuring patients receive timely global cutting-edge branded and targeted therapies. This truly achieves “treatment synchronized with international standards, drugs aligned with global availability.”

At the same time, the hospital fully supports medical insurance settlement for local patients. While providing international-standard pharmaceutical coverage, it effectively reduces the financial burden, making advanced treatments and innovative drugs accessible to more patients in need.

03 Deep Global Connections:

An International Ecosystem from “Bringing In” to “Going Global”

Royal Lee’s international journey began with serving global patients and evolved through building an in-depth global cooperation network.

In top-tier medical talent, the hospital has assembled a team of renowned experts with international vision. Led by Professor Li Dinggang, a distinguished specialist in comprehensive cancer treatment, the international medical team provides overseas patients with precision diagnosis and treatment plans consistent with global best practices, forming the backbone of the hospital’s international services.

In official cooperation, the hospital has established stable bilateral medical partnerships with the Consulates General in Guangzhou of Singapore, Indonesia, Pakistan, Nepal, and other countries. To date, it has provided high-quality medical services to patients from more than 30 countries and regions worldwide, becoming a key service hub for patients from Belt and Road countries in South China.

In advanced resource collaboration, the hospital has established strategic partnerships with multiple world-leading cancer centers, conducting regular international teleconsultations and joint clinics to ensure treatment plans remain fully synchronized with global frontiers. Supported by a strong pharmaceutical supply system, international treatment protocols are implemented in China with near-equivalent standards.

In humanistic services, the hospital’s dedicated International Medical Service Center employs a multilingual team covering English, Indonesian, Arabic, Thai, Russian, and other languages. It provides overseas patients with a full range of hassle-free support, including visa assistance, multilingual patient escort, concierge transportation, and customized accommodation services. The hospital features culturally respectful wellness wards, integrating the “hard power” of medical technology with the “soft power” of compassionate care, truly uniting treatment of the disease with care for the patient.

04 Empowering the Bay Area:

High-Level Healthcare Supporting a World-Class Business Environment

As the Sino-Singapore Guangzhou Knowledge City International Medical & Wellness Base, Guangzhou Royal Lee Cancer Hospital actively integrates its development into the overall development of the Greater Bay Area.

By enhancing regional capabilities in the diagnosis and treatment of complex and severe diseases and promoting international exchanges of advanced technologies, the hospital helps elevate the Greater Bay Area’s medical standards to an international level. More importantly, its internationally aligned high-quality medical care, efficient drug access, and patient-centered services significantly enhance the region’s attractiveness to overseas high-level talents and innovative enterprises, providing strong “health support” for optimizing the business environment and building a livable, world-class bay area.

From serving national strategies to connecting global resources, from refining technological strengths to building a pharmaceutical expressway — Guangzhou Royal Lee Cancer Hospital is writing a new chapter for China’s private healthcare on the international stage through a unique model of precision, efficiency, accessibility, and compassion.

In the future, the hospital will continue to uphold the philosophy of “Life First, Pursuit of Excellence”, committed to becoming a distinctive and trusted international brand in healthcare within the Guangdong-Hong Kong-Macao Greater Bay Area.